ACEPROMAZINE MALEATE I

The contract solicitation SPE2DP-26-T-4274, issued by the Defense Logistics Agency under the Department of Defense, seeks the procurement of ACEPROMAZINE MALEATE INJECTION, VETERINARY 10MG/ML 50ML VIAL, identified by NSN 6509-01-194-7255. The solicitation, posted on July 26, 2026, with a response deadline of August 3, 2026, requires electronic submission via the DLA Internet Bid Board System and is structured under simplified acquisition procedures, suggesting a likely fixed-price contract without options or extensions. Deliveries are to be made by July 24, 2026, to Kaiserslautern, Germany, under FOB Destination terms, meaning the contractor assumes all shipping costs and risks until receipt at the specified location. The total estimated value is $1,003.20, derived from multiple line items with varying unit prices for vial quantities ranging from one to four per entry, reflecting a consolidated procurement of veterinary pharmaceuticals. Compliance with stringent packaging, labeling, and safety standards is mandatory, including adherence to MIL-STD-2073-1E for preservation and packaging, and Medical Marking Standard No. 1 for labeling, which supersedes MIL-STD-129 for medical products. All hazardous materials must be labeled in accordance with OSHA’s Hazard Communication Standard (29 CFR 1910.1200), with Safety Data Sheets submitted prior to award. The contract includes multiple DFARS and FAR clauses addressing employment equity, human trafficking prevention, eligibility verification, sustainable purchasing, hazardous material disclosure, transportation by sea, cybersecurity compliance under NIST SP 800-171, whistleblower rights, and compensation restrictions for former DoD officials. Inspection and acceptance occur at the destination by the Government, and invoicing must be processed exclusively through WAWF using designated document types. Offerors must self-certify their small business status and socioeconomic categories, disclose Unique Entity Identifiers and CAGE codes if providing covered defense telecommunications, and affirm compliance with all applicable regulatory frameworks. No evaluation factors, weights, or award methodology are explicitly stated, though the context suggests a potential Lowest Price Technically Acceptable approach, with the Government retaining full discretion over award based on regulatory adherence and timely documentation.